GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Resonance Specialties Ltd (BOM:524218) » Definitions » Total Liabilities

Resonance Specialties (BOM:524218) Total Liabilities : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Resonance Specialties Total Liabilities?

Resonance Specialties's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Resonance Specialties's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹137.81 Mil) but then declined from Sep. 2024 (₹137.81 Mil) to Dec. 2024 (₹0.00 Mil).

Resonance Specialties's annual Total Liabilities increased from Mar. 2022 (₹49.70 Mil) to Mar. 2023 (₹101.01 Mil) and increased from Mar. 2023 (₹101.01 Mil) to Mar. 2024 (₹162.77 Mil).


Resonance Specialties Total Liabilities Historical Data

The historical data trend for Resonance Specialties's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Specialties Total Liabilities Chart

Resonance Specialties Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.90 139.58 49.70 101.01 162.77

Resonance Specialties Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 162.77 - 137.81 -

Resonance Specialties Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Resonance Specialties's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=114.804+(31.046+16.134
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.782+0)
=162.8

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=737.726-574.96
=162.8

Resonance Specialties's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resonance Specialties Total Liabilities Related Terms

Thank you for viewing the detailed overview of Resonance Specialties's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonance Specialties Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 54-D, Kandivli Industrial Estate, Kandivli (West), Charkop, Mumbai, MH, IND, 400067
Resonance Specialties Ltd is engaged in the manufacturing of chemicals. The company is manufacturing Pyridine, Picoline, Cynopyridine, and derivatives of the same. Bulk drugs and nutritional products are tolls converted. It delivers pyridine and related products. The company has only one segment which is Chemical Manufacturing. The company also manufactures anti-tuberculosis products such as Isoniazid. Geographically. It operates in India and Outside India. The majority of segment revenue is from Outside India.

Resonance Specialties Headlines

No Headlines